Roche Aktie
345,00
EUR
-0,40
EUR
-0,12
%
344,85
EUR
-1,10
EUR
-0,32
%
Roche jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Roche Aktie Analyse
| 21.07.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.07.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 20.07.22 | Roche Hold | Deutsche Bank AG | |
| 18.07.22 | Roche Overweight | Barclays Capital | |
| 18.07.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 14.07.22 | Roche Hold | Deutsche Bank AG | |
| 13.07.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.07.22 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
|
Werbung
|
|||
| 11.07.22 | Roche Neutral | UBS AG | |
| 07.07.22 | Roche Hold | Jefferies & Company Inc. | |
| 05.07.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 29.06.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 16.06.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.06.22 | Roche Hold | Deutsche Bank AG | |
| 07.06.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 06.06.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 27.05.22 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.05.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 26.05.22 | Roche Hold | Deutsche Bank AG | |
| 26.05.22 | Roche Outperform | Bernstein Research | |
| 19.05.22 | Roche Neutral | Credit Suisse Group | |
| 13.05.22 | Roche Hold | Jefferies & Company Inc. | |
| 12.05.22 | Roche Equal-weight | Morgan Stanley | |
| 12.05.22 | Roche Hold | Deutsche Bank AG | |
| 11.05.22 | Roche Outperform | Bernstein Research | |
| 11.05.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.05.22 | Roche Overweight | Barclays Capital | |
| 11.05.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 11.05.22 | Roche Sell | UBS AG | |
| 11.05.22 | Roche Buy | Jefferies & Company Inc. | |
| 05.05.22 | Roche Buy | Jefferies & Company Inc. | |
| 27.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.04.22 | Roche Neutral | Credit Suisse Group | |
| 26.04.22 | Roche Buy | Deutsche Bank AG | |
| 26.04.22 | Roche Overweight | Barclays Capital | |
| 25.04.22 | Roche Outperform | Bernstein Research | |
| 25.04.22 | Roche Sell | UBS AG | |
| 25.04.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 25.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.04.22 | Roche Buy | Jefferies & Company Inc. | |
| 19.04.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 19.04.22 | Roche Sell | UBS AG | |
| 13.04.22 | Roche Equal-weight | Morgan Stanley | |
| 12.04.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 12.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 31.03.22 | Roche Buy | Deutsche Bank AG | |
| 30.03.22 | Roche Overweight | Barclays Capital | |
| 30.03.22 | Roche Buy | Merrill Lynch & Co., Inc. | |
| 30.03.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 30.03.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
Werbung
Werbung